Journal of Multiple Sclerosis is one of the bets upcoming biomedical journals in the field of multiple sclerosis. The main aim of this journal is to publish the upcoming research findings and innovations in the field of multiple sclerosis. The journal is putting its efforts to highlight the research interventions in multiple sclerosis research.
Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. The plethora of potential therapeutic agents and the multiplicity of patterns and stages of disease to which each might be applied will demand tailoring of pivotal clinical trial designs to the specific clinical situation Vasiliki E. Kalodimou et al Multiple Sclerosis & Research.
Last date updated on January, 2021